Dose Escalation and Safety

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nexcella
NexcellaCA - Los Angeles
1 program
1
NXC-201Phase 11 trial
Active Trials
NCT04720313Active Not RecruitingEst. Jan 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
NexcellaNXC-201

Clinical Trials (1)

NCT04720313NexcellaNXC-201

NXC-201 (formerly HBI0101) Multiple Myeloma

Start: Jan 2021Est. completion: Jan 2027
Phase 1Active Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space